BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matoori S, Froehlich JM, Breitenstein S, Pozdniakova V, Reischauer C, Kolokythas O, Koh D, Gutzeit A. Serum albumin, total bilirubin, and patient age are independent confounders of hepatobiliary-phase gadoxetate parenchymal liver enhancement. Eur Radiol 2019;29:5813-22. [DOI: 10.1007/s00330-019-06179-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu C, Sun Y, Yang Y, Feng Y, Xie X, Qi L, Liu K, Wang X, Zhu Q, Zhao X. Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis. Eur Radiol 2021;31:5840-50. [PMID: 33533990 DOI: 10.1007/s00330-021-07702-6] [Reference Citation Analysis]
2 Chen L, Ke Z, Xiong F, Kan X, Ren Y, Cao Y, Sun T, Yan L, Zhou G, Zheng C. Platelet-to-lymphocyte ratio predicts therapy outcomes of transarterial chemoembolization plus apatinib in the treatment of advanced hepatocellular carcinoma. Anticancer Drugs 2020;31:966-72. [PMID: 31977568 DOI: 10.1097/CAD.0000000000000913] [Reference Citation Analysis]
3 Öcal O, Peynircioglu B, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Iezzi R, Benito A, Schütte K, Gasbarrini A, Seidensticker R, Wildgruber M, Pech M, Malfertheiner P, Ricke J, Seidensticker M. Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial. Eur Radiol 2021. [PMID: 34467453 DOI: 10.1007/s00330-021-08218-9] [Reference Citation Analysis]
4 Matoori S, Donners R, Garcia Nuñez D, Nguyen-duong S, Riopel C, Baumgartner M, Sartoretti E, Sartoretti T, Sartoretti-schefer S, Volm T, Fröhlich JM, Forstner R, Koh D, Gutzeit A. Transgender health and medicine – Are radiological devices prepared? European Journal of Radiology 2022;151:110320. [DOI: 10.1016/j.ejrad.2022.110320] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]